Early antiretroviral treatment may preserve key immune responses to HIV: Ragon Institute study findings could pave the way to vaccine development

Instituting combination antiretroviral (ART) treatment at the earliest stages of HIV infection may allow the generation of functional CD8 “killer” T cells and preservation of the CD4 helper T cells that are the virus’s primary

Engineered DNA vaccine protects against emerging Mayaro virus infection: New vaccine induces robust and specific immune responses and provides complete protection from disease in preclinical studies

A novel, synthetic DNA vaccine developed at The Wistar Institute induces protective immunity against Mayaro virus (MAYV), a mosquito-borne infection endemic to South America, that has the potential to become a global emerging viral threat.